the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
Status:
RECRUITING
Trial end date:
2024-12-29
Target enrollment:
Participant gender:
Summary
The name of this prospective study is a multicenter, open-label, randomized controlled clinical study of the efficacy and safety of Ondansetron Oral Soluble Pellicles for the prevention of delayed nausea and vomiting induced by highly emetogenic chemotherapy.
Phase:
PHASE3
Details
Lead Sponsor:
The First Affiliated Hospital of Xinxiang Medical College